EG23170A - Formulation of controlled release biodegradable (chitosan-gelatin) sponges containing tramadol hydrochloride as an analgesic drug - Google Patents

Formulation of controlled release biodegradable (chitosan-gelatin) sponges containing tramadol hydrochloride as an analgesic drug

Info

Publication number
EG23170A
EG23170A EG2002091068A EG2002091068A EG23170A EG 23170 A EG23170 A EG 23170A EG 2002091068 A EG2002091068 A EG 2002091068A EG 2002091068 A EG2002091068 A EG 2002091068A EG 23170 A EG23170 A EG 23170A
Authority
EG
Egypt
Prior art keywords
chitosan
gelatin
formulation
controlled release
tramadol hydrochloride
Prior art date
Application number
EG2002091068A
Inventor
Nagwa Hussein Fouda
Original Assignee
Nagwa Hussein Fouda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nagwa Hussein Fouda filed Critical Nagwa Hussein Fouda
Priority to EG2002091068A priority Critical patent/EG23170A/en
Application granted granted Critical
Publication of EG23170A publication Critical patent/EG23170A/en

Links

EG2002091068A 2002-09-25 2002-09-25 Formulation of controlled release biodegradable (chitosan-gelatin) sponges containing tramadol hydrochloride as an analgesic drug EG23170A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EG2002091068A EG23170A (en) 2002-09-25 2002-09-25 Formulation of controlled release biodegradable (chitosan-gelatin) sponges containing tramadol hydrochloride as an analgesic drug

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EG2002091068A EG23170A (en) 2002-09-25 2002-09-25 Formulation of controlled release biodegradable (chitosan-gelatin) sponges containing tramadol hydrochloride as an analgesic drug

Publications (1)

Publication Number Publication Date
EG23170A true EG23170A (en) 2004-06-30

Family

ID=32798685

Family Applications (1)

Application Number Title Priority Date Filing Date
EG2002091068A EG23170A (en) 2002-09-25 2002-09-25 Formulation of controlled release biodegradable (chitosan-gelatin) sponges containing tramadol hydrochloride as an analgesic drug

Country Status (1)

Country Link
EG (1) EG23170A (en)

Similar Documents

Publication Publication Date Title
PL2821067T3 (en) Rapid dissolution formulation of cinacalcet
EP1660043A4 (en) Immediate-release formulation of acid-labile pharmaceutical compositions
ATE454138T1 (en) MODIFIED RELEASE TABLET OF BUPROPION HYDROCHLORIDE
AU2002217373A1 (en) Controlled release pharmaceutical formulation containing venlafaxine
AU2003210733A1 (en) Rapid exchange catheter for delivery of vaso-occlusive devices
IL174560A0 (en) Controlled release formulations of opioid and nonopioid analgesics
GB0323908D0 (en) Pharmaceutical foam formulation
IL198996A (en) Use of an inhibitor of tyrosine kinases for preparation of a pharmaceutical composition
EP1691789A4 (en) Carvedilol free base, salts, anhydrous forms or solvate thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
MXPA05007609A (en) CaSR ANTAGONIST.
EG24479A (en) Modified release pharmaceutical formulation
AU2003243439A1 (en) Medical device for intra-lumenal delivery of pharmaceutical agents
AU2003230189A1 (en) Oral controlled release pharmaceutical composition containing metaxalone as active agent
IL165069A0 (en) Immediate release pharmaceutical formulation
AU2003216620A1 (en) Method of stabilizing bupropion hydrochloride tablets
EP1494650A4 (en) Pharmaceutical formulation comprising melatonin
IL164077A0 (en) Sustained release formulation of tramadol
EG23170A (en) Formulation of controlled release biodegradable (chitosan-gelatin) sponges containing tramadol hydrochloride as an analgesic drug
AU2003288760A1 (en) Controlled release formulation of tamsulosin hydrochloride and preparation process thereof
EP1547585A4 (en) Therapeutic agent for rheumatism containing benzamide derivative as active ingredient
AU2003280387A1 (en) Pharmaceutical formulation comprising azithrocycin monohydrate
IL174081A0 (en) Formulation for obtaining a pharmaceutical composition, methods of obtaining and use thereof
EP1617822A4 (en) Tablets and methods for modified release of hydrophilic and other active agents
AU2002351655A1 (en) Device for release of a drug containing oseltamivir and a h1 antagonist
HK1091120A1 (en) Method of preparing a formulation containing a microdosed active principle